Is RTX a buy, hold, or sell?
RTX carries a valuation grade of Strong Strong Buy. The trailing P/E of 33.6 sits 53% above the Industrials sector median of 22.0x — a premium that demands sustained earnings delivery. Our discounted cash flow model produces an intrinsic range of $171–$244 — implying a +15% margin of safety at the current price of $179.66. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.
With a 12% beat rate on recent quarters, earnings predictability has been mixed. The most recent quarter delivered a 16.9% earnings surprise. Analyst estimate revisions are trending upward.
What are RTX's key risk factors?
With a beta of 0.30, RTX exhibits a low-volatility risk profile relative to the broad market. The 95th-percentile CVaR of -12.8% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 1.3% of total portfolio loss in the worst 5% of months. Net margins of 8.0% fall below the Industrials sector average of 11%, suggesting margin pressure. The balance sheet is conservatively leveraged at 57% debt-to-equity.
At 0.77, the put/call ratio skews bullish, with call strong buyers dominating recent flow. Implied volatility of 33.4% exceeds realized volatility of 21.0% by 12 points, suggesting options are pricing in elevated risk. Insider transactions show net strong buying of $36.6M over the trailing period, a signal often associated with management confidence. Short interest is low at 1.1% of float, suggesting limited bearish conviction.
How does RTX fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — RTX carries a beta of 0.30, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all holdings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
Among closely correlated names, RTX shows the strongest co-movement with LHX (0.58), NOC (0.53), GD (0.45). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios.
True portfolio risk is a function of the full covariance structure across all holdings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The RTX analysis here is a single node in that larger structure.
For the full transatlantic conviction hierarchy — including RTX's position sizing, conviction rating, and upside/risk case in the 2026 defence supercycle — see: Defence Spending 2026: The Transatlantic Allocation Case →
